Showing results (2381-2390 of 2,546) with videos related to

Sort By:
Pageof 255
BMC Cardiovascular Disorders|January 8, 2026
Epidemiology of congenital heart defects in live births: findings from a study in Southern BrazilFabyanne Guimarães de Oliveira, George Octávio da Costa Salecker, Angel Larroza de Souza, et al.
American Journal of Hematology|August 11, 2025
Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter ExperienceBruno Fattizzo, Giacinto Luca Pedone, Elisabetta Metafuni, et al.
Nature Communications|March 8, 2025
Uncovering the rewired IAP-JAK regulatory axis as an immune-dependent vulnerability of LKB1-mutant lung cancerChangfa Shu, Jianfeng Li, Jin Rui, et al.
Hepatology Communications|June 19, 2024
AMPED study: Protocol for a randomized controlled trial of different doses of aerobic exercise trainingJonathan G Stine, Breianna Hummer, Nataliya Smith, et al.
Bone Marrow Transplantation|March 24, 2020
Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-BegelomabAndrea Bacigalupo, Emanuele Angelucci, Anna Maria Raiola, et al.
Journal of Clinical Medicine|December 9, 2023
Development of Bleeding Artificial Intelligence Detector (BLAIR) System for Robotic Radical ProstatectomyEnrico Checcucci, Pietro Piazzolla, Giorgia Marullo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2013
Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantationC Martínez, C Canals, B Sarina, et al.
British Journal of Haematology|July 22, 2025
Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOSNasheed M Hossain, Kwang Woo Ahn, Jinalben Patel, et al.
Science (New York, N.Y.)|March 11, 2017
Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependentAlice O Kamphorst, Andreas Wieland, Tahseen Nasti, et al.
Annals of Surgical Oncology|December 12, 2023
A Randomized Phase III Trial of Complete Mesocolic Excision Compared with Conventional Surgery for Right Colon Cancer: Interim Analysis of a Nationwide Multicenter Study of the Italian Society of Surgical Oncology Colorectal Cancer Network (CoME-in trial)Maurizio Degiuli, Aridai H Resendiz Aguilar, Mario Solej, et al.
Pageof 255